Craft

MaxiVAX

Total Funding

$8.1 M

MaxiVAX Summary

Company Summary

Overview
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. The company combines a vaccination process against the complete tumor cell with an immune system-boosting agent with its novel immunotherapy technology, thereby enabling cancer patients to get access to more treatment options.
Type
Private
Status
Active
Founded
2013
HQ
Genève, CH | view all locations
Website
http://www.maxivax.ch/
Cybersecurity rating
Sectors

Key People

  • Ksenija Pavletic

    Ksenija Pavletic, Executive Board Member and Director

    • Sven Zimmermann

      Sven Zimmermann, Director

      • Bruno Osterwalder

        Bruno Osterwalder, Chief Medical Advisor

        LocationsView all

        2 locations detected

        • Genève, GE HQ

          Switzerland

          Rue de l'Athénée 24

        • Genève, GE

          Switzerland

          Avenue de Sécheron 15

        Footer menu